These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32402087)

  • 1. Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
    Chhabra A; Robinson C; Houghton K; Cabral DA; Morishita K; Tucker LB; Petty RE; Larché M; Batthish M; Guzman J
    Rheumatology (Oxford); 2020 Dec; 59(12):3727-3730. PubMed ID: 32402087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
    Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and predictors of juvenile idiopathic arthritis in Southeast Asia: a Singapore longitudinal study over a decade.
    Teh KL; Tanya M; Das L; Hoh SF; Gao X; Arkachaisri T
    Clin Rheumatol; 2021 Jun; 40(6):2339-2349. PubMed ID: 33236179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
    Guzman J; Henrey A; Loughin T; Berard RA; Shiff NJ; Jurencak R; Huber AM; Oen K; Gerhold K; Feldman BM; Scuccimarri R; Houghton K; Chédeville G; Morishita K; Lang B; Dancey P; Rosenberg AM; Barsalou J; Bruns A; Watanabe Duffy K; Benseler S; Duffy CM; Tucker LB;
    J Rheumatol; 2019 Jun; 46(6):628-635. PubMed ID: 30647178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
    Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children.
    Tiller G; Buckle J; Allen R; Munro J; Gowdie P; Cox A; Akikusa J
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):69. PubMed ID: 30413164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study.
    Arnstad ED; Rypdal V; Peltoniemi S; Herlin T; Berntson L; Fasth A; Nielsen S; Glerup M; Ekelund M; Zak M; Aalto K; Nordal E; Romundstad PR; Rygg M;
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):961-969. PubMed ID: 30055093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
    Giancane G; Muratore V; Marzetti V; Quilis N; Benavente BS; Bagnasco F; Alongi A; Civino A; Quartulli L; Consolaro A; Ravelli A
    Arthritis Res Ther; 2019 Jul; 21(1):168. PubMed ID: 31287015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    Horton DB; Onel KB; Beukelman T; Ringold S
    J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan.
    Shen CC; Yeh KW; Ou LS; Yao TC; Chen LC; Huang JL
    J Microbiol Immunol Infect; 2013 Aug; 46(4):288-94. PubMed ID: 22727543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.
    Henrey A; Rypdal V; Rypdal M; Loughin T; Nordal E; Guzman J;
    Arthritis Res Ther; 2020 Jan; 22(1):10. PubMed ID: 31941530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Huber AM; Watanabe Duffy K; Boire G; Shiff N; Berard RA; Levy DM; Stringer E; Scuccimarri R; Morishita K; Johnson N; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Bruns A; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SM; Bolaria R; Gross K; Feldman B; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RS; Duffy CM; Tucker LB;
    Ann Rheum Dis; 2016 Jun; 75(6):1092-8. PubMed ID: 25985972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in juvenile idiopathic arthritis: a population-based study from Sweden.
    Berthold E; Månsson B; Kahn R
    Arthritis Res Ther; 2019 Oct; 21(1):218. PubMed ID: 31661011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
    Kearsley-Fleet L; Sampath S; McCann LJ; Baildam E; Beresford MW; Davies R; De Cock D; Foster HE; Southwood TR; Thomson W; Hyrich KL
    Rheumatology (Oxford); 2019 Feb; 58(2):331-335. PubMed ID: 30358861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review.
    Davies R; Gaynor D; Hyrich KL; Pain CE
    Semin Arthritis Rheum; 2017 Apr; 46(5):584-593. PubMed ID: 27914689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature.
    Halyabar O; Mehta J; Ringold S; Rumsey DG; Horton DB
    Paediatr Drugs; 2019 Dec; 21(6):469-492. PubMed ID: 31673960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    Guzman J; Henrey A; Loughin T; Berard RA; Shiff NJ; Jurencak R; Benseler SM; Tucker LB;
    J Rheumatol; 2017 Feb; 44(2):230-240. PubMed ID: 27980015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.
    Rypdal V; Arnstad ED; Aalto K; Berntson L; Ekelund M; Fasth A; Glerup M; Herlin T; Nielsen S; Peltoniemi S; Zak M; Rygg M; Rypdal M; Nordal E;
    Arthritis Res Ther; 2018 May; 20(1):91. PubMed ID: 29724248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.